ABOS
Acumen Pharmaceuticals, Inc.
1W: -17.7%
1M: -1.1%
3M: +31.2%
YTD: +33.2%
1Y: +111.8%
3Y: -34.5%
$2.67
-0.25 (-8.56%)
After Hours: $2.88 (+0.21, +7.87%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$161.7M
52W Range0.855-3.6
Volume441,018
Avg Volume810,433
Beta0.21
Dividend—
Analyst Ratings
Company Info
CEODaniel J. O'Connell
Employees61
SectorHealthcare
IndustryBiotechnology
IPO Date2021-07-01
Websiteacumenpharm.com
427 Park Street
Newton, VA 22902
US
Newton, VA 22902
US
434 297 1000
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Latest News
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives $6.80 Consensus Price Target from Analysts
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
Daniel Joseph Oconnell Sells 12,941 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| RA CAPITAL MANAGEMEN | A-Award | 6,060,606 | $3.30 | 2026-03-16 |
| Meisner Derek M | M-Exempt | 2,090 | $1.85 | 2026-03-06 |
| Meisner Derek M | S-Sale | 2,090 | $3.26 | 2026-03-06 |
| Meisner Derek M | M-Exempt | 2,090 | $1.85 | 2026-03-06 |
| Meisner Derek M | M-Exempt | 9,406 | $1.85 | 2026-02-27 |